Results

Total Results: 2,505 records

Showing results for "diseases".

181. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - Arthritis and nontraumatic joint disease 2. Cancer 3. Cardiovascular disease 4. … Infectious Disease, including HIV/AIDS 10. Obesity 11. Peptic ulcer disease and dyspepsia 12. … Pulmonary disease/asthma 14. Substance abuse 15. … For some diseases and conditions, reliable prevalence information has not been collected or published … X X X X X X X 24 Digestive Disease Week (DDW) 1, 11 Annual meeting presenting digestive disease

182. Ahrq Community Forum Webinar Branson (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq_community_forum_webinar_branson.pdf
     October 13, 2011 - SRA. 4 Characteristics of Patient Representatives • Have personal experience with the disease … • Are knowledgeable about treatment options and/or the science of the disease • Are able to be … groups may offer an opportunity to identify patients who might be underrepresented (such as for rare diseases … Advocacy experience – Ability to represent other patients/survivors – Knowledge and skills related to disease … area – Alternate disease experience – Work experience – Education • Interview representatives

183. Disposition of Comments for Treatment Strategies for Patients With Peripheral Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_disposition-comments.pdf
     May 29, 2013 - Disposition of Comments for Treatment Strategies for Patients With Peripheral Artery Disease … Comments Report Research Review Title: Treatment Strategies for Patients With Peripheral Artery Disease … Treatment Strategies for Patients With Peripheral Artery Disease. … The gaps and disease specific limitation section was particularly nice. … Dietary cholesterol and egg yolks: Not for patients at risk of vascular disease.

184. Comparative Effectiveness of Coronary Bypass Surgery and Percutaneous Coronary Interventions for Multivessel Disease: A Pooled Analysis of Individual Patient Data from Ten Randomized Trials (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
     February 01, 2010 - Comparative Effectiveness of Coronary Bypass Surgery and Percutaneous Coronary Interventions for Multivessel Disease … Consequently, patients with extensive three-vessel disease or left main disease were generally excluded … Continuing evolution of therapy for coronary artery disease. … Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. … PVD = peripheral vascular disease.

185. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
     September 13, 2011 - It is estimated that the direct medical costs of HCV-related diseases will top $10 billion over the … and chronic diseases.15-18 Patients who are infected with HCV but are considered to be at high risk … Disease Burden from Viral Hepatitis A, B, and C in the United States. … Daniels D, Grytdal S, Wasley A, for the Centers for Disease Control and Prevention. … Ghany MG, Strader DB, Thomas DL, et al, for the American Association for the Study of Liver Diseases

186. Updating the Measurement Criteria for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol-amendment.pdf
     December 28, 2023 - The report presents the latest available data on care quality and access to healthcare stratified by diseases … National Institute of Allergy and Infectious Diseases. … Quality indicators for acute cardiovascular diseases: a scoping review. … Definition of Terms Acronym Definition AHRQ Agency for Healthcare Research and Quality CDC Centers for Disease

187. Cervical Degenerative Disease Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cervical-degenerative-disease/protocol

188. Breast-Cancer-Medications Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
     July 01, 2012 - Tamoxifen, raloxifene, and tibolone do not increase risk for coronary heart disease events, although … : Examestane, an aromatase inhibitor, did not significantly increase risk for coronary heart disease … susceptibility/ or (disease adj5 susceptib$).mp. 4-2 or 3 5-1 and 4 6-(model$ or valid$).mp. 7-5 … -placebo: 118 Eligible for MAP- 3, not osteoporotic and not receiving drugs for bone related disease … Tamoxifen, raloxifene, and tibolone do not increase risk for coronary heart disease

189. DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
     May 01, 2012 - groups for hospital discharges, 10 diagnostic groups for outpatient visits, and 10 indicators of other diseases … However, the disease risk score estimates the probability or rate of disease (or outcome) occurrence … The association between exposure and disease (or outcome) is then estimated adjusting for the disease … Disease Risk Score Calculation Given that the disease risk score estimates the probability of disease … Disease Risk Score Assessment The disease risk score is often categorized into groups such that the

190. Executive Summary: Radiation Therapy for Metastatic Bone Disease: Effectiveness and Harms (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-summary.pdf
     August 01, 2023 - Executive Summary: Radiation Therapy for Metastatic Bone Disease: Effectiveness and Harms Comparative … Effectiveness Review Number 265 Radiation Therapy for Metastatic Bone Disease: Effectiveness … intended audiences for this • In patients having initial palliative radiation for metastatic bone disease … events; BPI = Brief Pain Inventory; EBRT = external beam radiation therapy; MBD = metastatic bone disease … Radiation Therapy for Metastatic Bone Disease: Effectiveness and Harms.

191. Roblin_final (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/roblin.pdf
     January 01, 2010 - www.effectivehealthcare.ahrq.gov/index.cfm) � • Chronic diseases … • Excellent evidence for the importance of self-­‐monitoring and self-­‐management in chronic  diseases … with and without  peer supporters Slide 21: Summary (1) • Integrating mobile ICT into chronic disease … dissemination  of effective practices by mobilizing social support for self-­‐ management of chronic disease … Accessible technology already exists that can be integrated into systems to engage patients in  chronic disease

192. Rapid Evidence Product_Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
     October 01, 2022 - Background 2 (LVEF), disease in multiple coronary vessels, and/or disease in the proximal portion … Optimal treatment strategies for coronary artery disease in patients with advanced kidney disease: … Management of Coronary Disease in Patients with Advanced Kidney Disease. N Engl J Med. … "[Mesh] OR "coronary artery disease"[tiab] OR "coronary heart disease"[tiab] Guideline, Meta- Analysis … '/exp OR 'coronary artery disease':ti,ab OR 'coronary heart disease':ti,ab 584588 2 debulking:ti

193. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/phenylketonuria_research-protocol.pdf
     March 29, 2011 - Treating the disease also involves monitoring Phe concentrations in the blood on a regular basis, as … Journal of Inherited Metabolic Diseases. 2007; 30:145-152. 11. Guttler F, Guldberg P. … Journal of Inherited Metabolic Diseases. 2009; 32:472- 480. … Journal of Inherited Metabolic Diseases. 2007; 30:145-152. 11. Guttler F, Guldberg P. … Journal of Inherited Metabolic Diseases. 2009; 32:472-480. 17. van Spronsen FJ.

194. Crosscutting-Horizon-Scan-High-Impact-1406 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - be used during gastrointestinal endoscopy procedures for benign conditions, such as peptic ulcer disease … of American Anesthesiologist (ASA) physical performance status IV (patients with severe systemic disease … number (n=17) of the overall patient population had an ASA performance status of III (severe systemic disease … Education: residency and continuing medical education should include unique physiology, atypical disease … 20Meeting/Meetign%20Content/A M13%20presentations/Abstract-Session-B3- Organization-of-Care-and-Chronic-Disease

195. Topic 0484 Treatments for Fecal Incontinence NSD FINAL SJ (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0572-140408.pdf
     January 09, 2014 - conditions such as irritable bowel syndrome (IBS), diarrhea, constipation, and inflammatory bowel diseases

196. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0193_08-12-2009.pdf
     January 01, 2009 -  Prescription medication adherence is a significant barrier to improving patient outcomes in many diseases

197. Survey of Medicare Part D Plans’ Medication Therapy Management Programs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
     January 01, 2007 - Beneficiaries that qualify for MTM services are persons with multiple chronic diseases, on multiple … median number (range) of disease states were 3 (2-5). … Many programs further restricted enrollment by limiting the conditions from which the chronic diseases … Number of chronic diseases required for enrollment in a MTM program. … What are the disease requirements (number of diseases, specific diseases) for enrollees to be eligible

198. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/11_peptic_ulcer_potential_high_impact_2012-12-111.pdf
     January 01, 2012 - (e.g., Crohn’s disease, ulcerative colitis [UC]). … (The therapy has also recently been identified as being explored for other autoimmune diseases such … The rationale for this treatment stems from observing that inflammatory bowel diseases are rare in … National Digestive Diseases Information Clearinghouse (NDDIC). … National Digestive Diseases Information Clearinghouse. Short bowel syndrome. [internet].

199. Executive Summary CER 171: Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
     March 01, 2011 - Executive Summary CER 171: Noninvasive Testing for Coronary Artery Disease 1 Comparative Effectiveness … artery disease (CAD) are substantial. … Guideline states that diagnostic testing is most valuable when the pretest probability of ischemic heart diseases … Guideline states that diagnostic testing is most valuable when the pretest probability of ischemic heart diseases … Robbins & Cotran Pathophysiologic Basis of Disease. 9th ed. Philadelphia: W. B.

200. Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
     August 01, 2012 - No mention of auto immune diseases such as vasculitis? 1. … did not identify trials that reported a substantial prevalence of vasculitis or other auto immune diseases … ―CKD as an Underrecognized Threat to Patient Safety.‖ American Journal of Kidney Diseases, Vol 53, … The draft CER focuses on endpoints for end-stage renal disease (ESRD), cardiovascular disease (CVD) … The overlap of co-morbid diseases is common enough that in the case of isolated CKD, there is likely